StemInov will bioproduct the first cell therapy drug from umbilical cord stem cells for the treatment of inflammatory diseases, septic shock, and acute respiratory distress syndrome.
[StemInov [Businesswire]]
Home Newsletters StemInov will Bioproduct the First Cell Therapy Drug To Treat Inflammatory Diseases
